tiprankstipranks
Trending News
More News >
Grace Therapeutics (GRCE)
NASDAQ:GRCE
US Market

Grace Therapeutics (GRCE) Income Statement

Compare
1,172 Followers

Grace Therapeutics Income Statement

Last quarter (Q2 2026), Grace Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q2, Grace Therapeutics's net income was C$-938.00K. See Grace Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 196.00K
Gross Profit
C$ 0.00C$ -11.00KC$ 0.00C$ 0.00C$ 120.00K
Operating Expenses
C$ 16.68MC$ 11.30MC$ 52.16MC$ 15.59MC$ 16.54M
Depreciation and Amortization
C$ 7.00KC$ 11.00KC$ 124.00KC$ 0.00C$ 924.00K
EBITDA
C$ -16.67MC$ -14.62MC$ -18.12MC$ -15.34MC$ -9.79M
Operating Income
C$ -16.68MC$ -11.31MC$ -52.16MC$ -15.59MC$ -16.42M
Other Income/Expenses
C$ 3.91MC$ -3.32MC$ 184.00KC$ 5.12MC$ -3.26M
Pretax Income
C$ -12.77MC$ -14.63MC$ -51.97MC$ -10.47MC$ -19.68M
Net Income
C$ -9.57MC$ -12.85MC$ -42.43MC$ -9.82MC$ -19.68M
Per Share Metrics
Basic EPS
C$ -0.79C$ -1.73C$ -5.71C$ -1.60C$ -7.98
Diluted EPS
C$ -0.79C$ -1.73C$ -5.71C$ -1.60C$ -7.98
Weighted Average Shares Outstanding
12.09M 7.44M 7.43M 6.14M 2.47M
Weighted Average Shares Outstanding (Diluted)
12.09M 7.44M 7.43M 6.14M 2.47M
Currency in CAD

Grace Therapeutics Earnings and Revenue History